OA06883A - Préparation de capsules contenant un ménalgésique et une matière alcaline. - Google Patents

Préparation de capsules contenant un ménalgésique et une matière alcaline.

Info

Publication number
OA06883A
OA06883A OA57476A OA57476A OA06883A OA 06883 A OA06883 A OA 06883A OA 57476 A OA57476 A OA 57476A OA 57476 A OA57476 A OA 57476A OA 06883 A OA06883 A OA 06883A
Authority
OA
OAPI
Prior art keywords
menalgic
preparation
capsules containing
alkaline material
alkaline
Prior art date
Application number
OA57476A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/179,191 external-priority patent/US4294819A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of OA06883A publication Critical patent/OA06883A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA57476A 1980-08-18 1981-08-18 Préparation de capsules contenant un ménalgésique et une matière alcaline. OA06883A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/179,191 US4294819A (en) 1980-08-18 1980-08-18 Alkaline analgesic capsule
US06/273,015 US4339428A (en) 1980-08-18 1981-06-18 Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component

Publications (1)

Publication Number Publication Date
OA06883A true OA06883A (fr) 1983-04-30

Family

ID=26875096

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57476A OA06883A (fr) 1980-08-18 1981-08-18 Préparation de capsules contenant un ménalgésique et une matière alcaline.

Country Status (25)

Country Link
US (1) US4339428A (fr)
AT (1) AT370624B (fr)
AU (1) AU549488B2 (fr)
CA (1) CA1156554A (fr)
CH (1) CH646331A5 (fr)
DD (1) DD201643A5 (fr)
DE (1) DE3132518A1 (fr)
DK (1) DK159374C (fr)
ES (1) ES504797A0 (fr)
FI (1) FI77371C (fr)
FR (1) FR2488508A1 (fr)
GB (1) GB2082456B (fr)
GR (1) GR74618B (fr)
HU (1) HU187354B (fr)
IE (1) IE51501B1 (fr)
IL (1) IL63577A0 (fr)
IT (1) IT1143221B (fr)
LU (1) LU83559A1 (fr)
NL (1) NL8103804A (fr)
NO (1) NO155476C (fr)
NZ (1) NZ198045A (fr)
OA (1) OA06883A (fr)
PT (1) PT73530B (fr)
SE (1) SE451667B (fr)
ZW (1) ZW19781A1 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
EP0166315B1 (fr) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Microcomprimés cylindriques gastrorésistants à base de pancréatine
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
EP0320550A1 (fr) * 1987-12-18 1989-06-21 Bristol-Myers Company Composition NSAID contenant des bloqueurs H1, bloqueurs H2, agonistes bêta-adrénergiques ou leurs mélanges et un agent alcalinisant
US5071842A (en) * 1988-10-14 1991-12-10 Bristol-Myers Squibb Company Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
JP3230814B2 (ja) * 1989-09-15 2001-11-19 シーマ・ラブス、インコーポレイション 炭酸マグネシウムおよびオイルタブレット形成助剤
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
NZ243567A (en) * 1991-07-22 1995-04-27 Bristol Myers Squibb Co Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
US5391230A (en) * 1993-07-07 1995-02-21 Eastman Kodak Company Apparatus for holding solid compact medicaments during processing
HUT76798A (en) * 1994-09-02 1997-11-28 Univ Virginia Commonwealth Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
US6274592B1 (en) 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US6511494B1 (en) 2000-11-17 2003-01-28 Embro Corporation Vein harvesting system and method
US6887492B2 (en) * 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
US6576665B2 (en) * 2001-04-03 2003-06-10 Braintree Laboratories, Inc. Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
JP2005531495A (ja) * 2001-12-21 2005-10-20 シャイア ラボラトリーズ，インコーポレイテッド 高い物理的安定性を有する経口カプセル製剤
MXPA05013147A (es) * 2003-06-06 2006-03-17 Takeda Pharmaceutical Preparacion solida.
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050282756A1 (en) * 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
US20060222705A1 (en) * 2005-03-31 2006-10-05 Flanner Henry H Pharmaceutical tablet and apparatus and method for making
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
DE102008025798C5 (de) 2008-05-29 2015-08-06 Guangdong Fushan Glass Machinery Co., Ltd. Verfahren zum Betreiben eines Rollenofens
WO2011008546A2 (fr) * 2009-06-29 2011-01-20 Capricorn Pharma, Inc. Formes posologiques solides ou semi-solides et systèmes et procédés de formation et de conditionnement de celles-ci
WO2011085022A1 (fr) 2010-01-05 2011-07-14 Microdose Therapeutx, Inc. Dispositif et procédé d'inhalation
US20130143867A1 (en) * 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
IL230419A0 (en) 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses
CA2914365C (fr) 2013-06-05 2022-03-15 Synchroneuron, Inc. Formulations d'acamprosate, procedes d'utilisation de celles-ci, et combinaisons comprenant celles-ci
WO2017062951A1 (fr) * 2015-10-09 2017-04-13 Binutra Incorporated Capsule à diaphragme interne à volume ajustable

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA593581A (en) * 1960-03-01 W. E. Harrisson Joseph Analgesic product
FR808949A (fr) * 1936-07-31 1937-02-18 Perfectionnements à la préparation des cachets pharmaceutiques
US2224256A (en) * 1938-08-05 1940-12-10 Baker Chem Co J T Pharmaceutical preparation
GB613080A (en) * 1946-05-17 1948-11-22 Myer Coplans Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
US2698332A (en) * 1951-04-20 1954-12-28 Reheis Company Inc Aspirin derivative and method of making
GB754364A (en) * 1953-10-09 1956-08-08 Drug Houses Of Australia Ltd Improvements in medicinal preparations containing acetylsalicylic acid
US2918485A (en) * 1955-09-21 1959-12-22 Keystone Chemurgic Corp Dihydroxy aluminum salicylates
US2889248A (en) * 1955-12-13 1959-06-02 Drug Processors Inc Therapeutic composition containing aluminum proteinate
US2801951A (en) * 1956-01-09 1957-08-06 Sterling Drug Inc Stabilized analgesic compositions
GB827529A (en) * 1956-02-27 1960-02-03 Macleans Ltd Improvements in or relating to the manufacture of tablets
US2888382A (en) * 1957-10-28 1959-05-26 Upjohn Co Therapeutic composition and process
NL245245A (fr) * 1958-04-18
US3019169A (en) * 1958-06-23 1962-01-30 Sterling Drug Inc Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process
US3323992A (en) * 1960-09-29 1967-06-06 Keystone Chemurgic Corp Antacid composition of hydrated magnesium aluminate containing bound sulfate
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
GB1204580A (en) 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3608064A (en) * 1969-10-07 1971-09-21 Anthony H Lamb Milk-buffered aspirin
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule

Also Published As

Publication number Publication date
PT73530A (en) 1981-09-01
NL8103804A (nl) 1982-03-16
FI77371B (fi) 1988-11-30
NO812678L (no) 1982-02-19
DD201643A5 (de) 1983-08-03
ES8301622A1 (es) 1982-12-16
ZW19781A1 (en) 1982-06-16
IE811881L (en) 1982-02-18
DK362781A (da) 1982-02-19
GB2082456B (en) 1984-10-24
HU187354B (en) 1985-12-28
FI812505L (fi) 1982-02-19
FI77371C (fi) 1989-03-10
US4339428A (en) 1982-07-13
NO155476C (no) 1987-04-08
SE451667B (sv) 1987-10-26
IL63577A0 (en) 1981-11-30
AT370624B (de) 1983-04-25
IT1143221B (it) 1986-10-22
DE3132518A1 (de) 1982-05-27
LU83559A1 (fr) 1982-04-14
DK159374C (da) 1991-07-01
NZ198045A (en) 1985-01-31
GR74618B (fr) 1984-06-29
IE51501B1 (en) 1987-01-07
NO155476B (no) 1986-12-29
DK159374B (da) 1990-10-08
CA1156554A (fr) 1983-11-08
ATA355281A (de) 1982-09-15
SE8104881L (sv) 1982-02-19
PT73530B (en) 1983-10-20
FR2488508B1 (fr) 1985-05-10
FR2488508A1 (fr) 1982-02-19
AU7368281A (en) 1982-02-25
AU549488B2 (en) 1986-01-30
ES504797A0 (es) 1982-12-16
CH646331A5 (de) 1984-11-30
IT8149078A0 (it) 1981-08-10
GB2082456A (en) 1982-03-10

Similar Documents

Publication Publication Date Title
OA06883A (fr) Préparation de capsules contenant un ménalgésique et une matière alcaline.
GB2151201B (en) Masticatory gelatin capsules
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
MC1418A1 (fr) 2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances
BE890008A (fr) Capsule analgesique alcaline
BE892805A (fr) Cycloalcanes substitues et compositions pharmaceutiques les contenant
FR2524897B1 (fr) Composes du polyglycerol et produits cosmetiques les contenant
NL990031I1 (nl) Farmaceutische preparen die N-gesubstitueerde 3-hydroxypyrid-2-on of 4-onderivaten bevatten.
BE886377A (fr) Formulations solides contenant des pheromones
DK37981A (da) Kapsler indeholdende cementholdige blandinger
FR2597472B1 (fr) Composes difluorohalogenomethoxyphenyle et compositions acaricides les contenant.
FR2527597B1 (fr) Derives d'alcool b,g-dihydropolyprenylique et composition pharmaceutique contenant un compose polyprenylique
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
IT1117201B (it) Medicamento anticanceroso e di prevenzione per metastasi cancerose
BE895756A (fr) Perfluorocyclo-amines et preparation en emulsion contenant ces perfluorocyclo-amines
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
DE2966178D1 (en) Compounds of the muramyl-peptide type and medicines containing them
BE879327A (fr) Preparation de bandes de matiere contenant une rangee de poches
BE884530A (fr) Nouveaux hexahydro-trans-pyrido-indoles et composition pharmaceutique les contenant
FR2343477A1 (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant
BE894162A (fr) Nouveau sel de n-methyl-d-glucamine et medicament le contenant
BE867040A (fr) Composition pharmaceutique contenant un nitro-imidazole
BE883859A (fr) Nouveaux pyridylaminotriazoles et composition pharmaceutique les contenant